The role of targeted focal therapy in the management of low-risk prostate cancer: update on current challenges
{{output}}
Prostate cancer is one of the most prevalent cancers among men in the United States, second only to nonmelanomatous skin cancer. Since prostate-specific antigen (PSA) testing came into widespread use in the late 1980s, there has been a sharp increase in annual... ...
